1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Long-term prevention of bladder cancer progression by alpha1-oleate alone or in combination with chemotherapy
(
- Contribution to journal › Article
-
Mark
Sustained delivery of a heterodimer bone morphogenetic protein-2/7 via a collagen hydroxyapatite scaffold accelerates and improves critical femoral defect healing
(
- Contribution to journal › Article
- 2022
-
Mark
Immunomodulation therapy offers new molecular strategies to treat UTI
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex
(
- Contribution to journal › Article
-
Mark
Molecular determinants of disease severity in urinary tract infection
(
- Contribution to journal › Scientific review
-
Mark
A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer
(
- Contribution to journal › Article
-
Mark
Immunomodulation—A Molecular Solution to Treating Patients with Severe Bladder Pain Syndrome?
(
- Contribution to journal › Article
-
Mark
Collateral effects of deletion of nlpD on rpoS and rpoS-dependent genes. Reply.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A scientific journey from discovery to validation of efficacy in cancer patients : HAMLET and alpha1-oleate
(
- Contribution to journal › Article
-
Mark
Active bacterial modification of the host environment through RNA polymerase II inhibition
(
- Contribution to journal › Article